Related Experiment Videos

Experimental study on the comparative thrombolytic effects of intracoronary and intravenous administration of

Insights

Intracoronary urokinase (UK) effectively achieved coronary thrombolysis in 77% of cases. Intravenous UK showed variable success rates depending on dosage, with higher doses yielding better results.

Area of Science:

  • Cardiovascular Research
  • Pharmacology
  • Experimental Medicine

Background:

  • Coronary thrombolysis is crucial for treating myocardial infarction.
  • Assessing the efficacy of different administration routes for thrombolytic agents is essential.

Purpose of the Study:

  • To evaluate the effectiveness of intracoronary (i.c.) and intravenous/intraventricular (i.v./i.vt.) urokinase (UK) for coronary thrombolysis.
  • To compare the success rates of UK administration via different routes in a canine model.

Main Methods:

  • A canine model was used to induce coronary thrombus via electrical stimulation.
  • Urokinase (UK) was administered via intracoronary, intravenous, or intraventricular routes at varying dosages.
  • Coronary thrombolysis success rates and fibrinogen levels were measured.

Main Results:

  • Intracoronary UK administration (4,000 U/Kg) achieved a 77% success rate in coronary thrombolysis.
  • Low-dose intravenous/intraventricular UK (<24,000 U/Kg) had a 25% success rate.
  • High-dose intravenous UK (>25,000 U/Kg) resulted in a 64% success rate and significant fibrinogen reduction.

Conclusions:

  • Intracoronary administration of urokinase is a highly effective method for coronary thrombolysis.
  • Higher doses of intravenous urokinase demonstrate significant thrombolytic efficacy, accompanied by reduced fibrinogen levels.

Related Concept Videos